Clinical Trial Update: Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the combination of oxaliplatin with fluorouracil and leucovorin for recurrent or metastatic esophageal or gastric cancer. The study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Chicago | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED